Free CE/CMEVideo

Precision Pathways in 𝘙𝘈𝘚-Mutant GI Malignancies

Release Date

November 16, 2026

Expiration Date

November 17, 2027

Credits

2.0 CME, NCPD

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in gastrointestinal (GI) oncology. In this educational program, these experts discuss the biology of RAS mutations and the evolving role of RAS-directed therapies in pancreatic and colorectal cancer. Through case-based learning and panel discussions, faculty place emerging efficacy and safety data in the context of real-world treatment decisions.

This educational activity is an archive of the live symposium held on October 2, 2026.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, radiologists, general scientists, young investigators, advanced practice providers, nurses, and pharmacists interested in GI oncology. Other health care professionals interested in treating these malignancies are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Evaluate efficacy and safety data from clinical trials of RAS-directed therapies in GI cancers
  • Incorporate emerging clinical evidence into personalized treatment strategies for patients with GI malignancies
  • Apply proactive strategies to monitor and manage treatment-related toxicities associated with RAS-directed therapies in GI cancers
Precision Pathways in 𝘙𝘈𝘚-Mutant GI Malignancies

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Revolution Medicines, Inc.

Follow Us on Social Media!

You Also Might Like...

Course

Precision Pathways in 𝘙𝘈𝘚-Mutant GI Malignancies

Create Account